Unknown

Dataset Information

0

FAM122A promotes acute myeloid leukemia cell growth through inhibiting PP2A activity and sustaining MYC expression.

ABSTRACT:

SUBMITTER: Liu MH 

PROVIDER: S-EPMC7928003 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

FAM122A promotes acute myeloid leukemia cell growth through inhibiting PP2A activity and sustaining MYC expression.

Liu Man-Hua MH   Chen Jing J   Yang Yun-Sheng YS   Wang Yin-Qi YQ   Chen Guo-Qiang GQ   Zhang Yu Y   Huang Ying Y  

Haematologica 20210301 3

Similar Datasets

Unknown Chidamide and cytarabine synergistically treat acute myeloid leukemia: inhibiting ribosome biogenesis via the MYC-RRP9 pathway
| S-EPMC12334614 | biostudies-literature
Unknown Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19.
| S-EPMC10491220 | biostudies-literature
Unknown Cryo-EM structures of PP2A:B55-FAM122A and PP2A:B55-ARPP19.
| S-EPMC10765524 | biostudies-literature
Unknown FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs.
| S-EPMC11233601 | biostudies-literature
Unknown SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
| S-EPMC3973087 | biostudies-literature
Unknown Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
| S-EPMC6895887 | biostudies-literature
Unknown Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia.
| S-EPMC7494214 | biostudies-literature
Unknown PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
| S-EPMC8900275 | biostudies-literature
Unknown PAK4 phosphorylates and stabilizes MYC to promote acute myeloid leukemia
| S-EPMC12375255 | biostudies-literature
Unknown Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia.
| S-EPMC2877934 | biostudies-literature